Activated Met Signalling in the Developing Mouse Heart Leads to Cardiac Disease
2011

How Met Signaling Affects Heart Development in Mice

publication 10 minutes Evidence: moderate

Author Information

Author(s): Leo Christian Sala, Valentina Morello, Mara Chiribiri, Amedeo Riess, Daniele Mancardi, Stefano Schiaffino, Carola Ponzetto, Tiziana Crepaldi

Primary Institution: University of Turin

Hypothesis

What is the role of Met signaling in cardiac development and its implications for cardiac disease?

Conclusion

Excessive activation of the HGF/Met system during development can lead to cardiac damage and may be involved in the pathogenesis of cardiac disease.

Supporting Evidence

  • Met is present in neonatal cardiomyocytes and responds to HGF.
  • Exogenous HGF enhances cardiac proliferation but reduces key proteins in newborn mice.
  • Adult transgenic mice with HGF expression show systolic dysfunction.
  • Prenatal expression of Tpr-Met leads to lethal outcomes after birth.

Takeaway

This study shows that too much of a certain growth factor in developing hearts can cause problems later on, like heart disease.

Methodology

The study involved generating transgenic mice with cardiac-specific expression of HGF or activated Met to observe the effects on heart development.

Limitations

The study primarily focuses on mouse models, which may not fully replicate human cardiac development and disease.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pone.0014675

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication